Literature DB >> 19005244

Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.

E Hohenstein1, P L Rady, M Hergersberg, A R Huber, S K Tyring, T Bregenzer, M Streit, P Itin.   

Abstract

BACKGROUND: Epidermodysplasia verruciformis (EV) is a rare autosomal-recessive disorder characterized by widespread and persistent infection with human papilloma virus (HPV) and a risk of malignant degeneration. Most cases of EV are caused by mutations in the two EV genes, EVER1/TMC6 and EVER2/TMC8. The clinical presentation of EV takes two different forms, which coexist in most cases. Over a period of years, patients develop plane warts and pityriasis versicolor-like lesions. Sixteen cases of EV in HIV-positive patients have been clinically investigated and reported in the literature. However, different inherited susceptibilities towards HPV infection in immunodeficient patients, like HIV-positive patients, have only rarely been addressed. OBSERVATION: We describe a 22-year-old female patient with a congenital HIV infection, who presented with slowly progressing and confluent erythematous papules on her hands and hypopigmented macules on her extremities. The histopathology was typical for EV, and HPV5 was detected by PCR and reverse hybridization. The 44-year-old HIV-positive mother has no typical EV lesions. The patient is homozygous for an A to T single nucleotide polymorphism (SNP) at position 917 of the TMC8/EVER2 gene. The mother of the patient is heterozygous for this SNP.
CONCLUSION: These results support the hypothesis that the combination of immunodeficiency and a susceptibility allele may contribute to the differences in occurrence of EV in HIV-positive patients. Copyright (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005244     DOI: 10.1159/000174084

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

Review 1.  Dermatologic manifestations of HPV in HIV-infected individuals.

Authors:  Rachel H Gormley; Carrie L Kovarik
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

2.  Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescents in Zimbabwe.

Authors:  S M Lowe; L Katsidzira; R Meys; J C Sterling; M de Koning; W Quint; K Nathoo; S Munyati; C E Ndhlovu; J R Salisbury; C B Bunker; E L Corbett; R F Miller; R A Ferrand
Journal:  Clin Infect Dis       Date:  2012-04-03       Impact factor: 9.079

Review 3.  The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.

Authors:  Agnieszka Kalińska-Bienias; Cezary Kowalewski; Sławomir Majewski
Journal:  Postepy Dermatol Alergol       Date:  2016-05-16       Impact factor: 1.837

4.  EVER2 protein binds TRADD to promote TNF-α-induced apoptosis.

Authors:  G Gaud; D Guillemot; Y Jacob; M Favre; F Vuillier
Journal:  Cell Death Dis       Date:  2013-02-21       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.